Cargando…

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation

Patient-specific human-induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs) may be produced, genome-edited, and differentiated into multiple cell types for regenerative medicine, disease modeling, drug testing, toxicity screening, and three-dimensional tissue fabrication. There i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leowattana, Wattana, Leowattana, Tawithep, Leowattana, Pathomthep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516943/ https://www.ncbi.nlm.nih.gov/pubmed/36186184 http://dx.doi.org/10.12998/wjcc.v10.i27.9588

Ejemplares similares

Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022)

Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

COVID-19 vaccination and cardiac dysfunction
por: Leowattana, Wattana, et al.
Publicado: (2022)

Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022)

Dengue hemorrhagic fever and the liver
por: Leowattana, Wattana, et al.
Publicado: (2021)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Tuberculosis of the spine
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatment for advanced pancreatic cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
por: Leowattana, Wattana
Publicado: (2021)

Nucleos(t)ide analogues treatment outcome in genotype B and C chronic hepatitis B
por: Aung, Myo Nyein, et al.
Publicado: (2010)

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
por: Christ, Torsten, et al.
Publicado: (2021)

Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
por: Shiti, Assad, et al.
Publicado: (2021)

Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations
por: Jiang, Yanqing, et al.
Publicado: (2018)

Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules
por: Sibmooh, Nathawut, et al.
Publicado: (2004)

Risk perception of health problems among travelers visiting a travel clinic in Bangkok, Thailand
por: Hiranrusme, Thanyapat, et al.
Publicado: (2020)

Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
por: Higo, Shuichiro
Publicado: (2023)

Personalized medicine and atrial fibrillation: will it ever happen?
por: Lubitz, Steven A, et al.
Publicado: (2012)

Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation
por: Liang, Jackson J, et al.
Publicado: (2016)

Mimicking platelet indices in patients with malaria and dengue hemorrhagic fever: characteristics and clinical applications
por: Mon, Nant The Su, et al.
Publicado: (2022)

Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021)

Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes
por: Argenziano, Mariana, et al.
Publicado: (2018)

Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation
por: Hong, Liang, et al.
Publicado: (2021)

Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand
por: Thu, Aung Myint, et al.
Publicado: (2015)

Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia
por: Thorpe, Jordan, et al.
Publicado: (2023)

Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System
por: Bektik, Emre, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship
por: Batta, Akash, et al.
Publicado: (2023)

Induced pluripotent stem cell–derived human platelets: one step closer to the clinic
por: Gekas, Christos, et al.
Publicado: (2010)

Prediction and personalised treatment of atrial fibrillation—stroke prevention: consolidated position paper of CVD professionals
por: Helms, Thomas M, et al.
Publicado: (2014)

Induced pluripotent stem cells free of exogenous reprogramming factors
por: Abujarour, Ramzey, et al.
Publicado: (2009)

Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
por: Devalla, Harsha D, et al.
Publicado: (2015)

Paroxysmal atrial fibrillation ablation: Achieving permanent pulmonary vein isolation by point-by-point radiofrequency lesions
por: Pedrote, Alonso, et al.
Publicado: (2017)

Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression
por: Josowitz, Rebecca, et al.
Publicado: (2014)

Drug screening platform using human induced pluripotent stem cell‐derived atrial cardiomyocytes and optical mapping
por: Gunawan, Marvin G., et al.
Publicado: (2020)

Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists
por: Ahmad, Faizzan S., et al.
Publicado: (2023)

Human pluripotent stem cell-derived extracellular vesicles: From now to the future
por: de Matos, Bruno Moises, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f3lajrg6b7lve8cv7na4i9pf1k